SCHEMBL9744696

SCHEMBL9744696

CCCOC(=O)C(N)C=CCP(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LAP3 P28838 3/20 0.33
METAP1 P53582 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
S1PR4 O95977 2/20 0.31
S1PR1 P21453 2/20 0.31
S1PR3 Q99500 2/20 0.31
S1PR5 Q9H228 2/20 0.31
S1PR2 O95136 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSPO P30536 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9744681 1.00 CYP2D6 (0.42) CYP2D6CYP2C9CYP2C19LAP3METAP1
SCHEMBL9746246 0.91 CYP2D6 (0.40) CYP2D6CYP2C9CYP2C19LAP3HCAR2
SCHEMBL9746256 0.91 CYP2D6 (0.40) CYP2D6CYP2C9CYP2C19LAP3HCAR2
SCHEMBL9743034 0.89 LAP3 (0.40) CYP2D6CYP2C9CYP2C19LAP3P2RY10
SCHEMBL9743040 0.89 LAP3 (0.40) CYP2D6CYP2C9CYP2C19LAP3P2RY10
SCHEMBL9745364 0.88 LAP3 (0.41) LAP3S1PR4S1PR1S1PR3S1PR5
SCHEMBL9742668 0.88 LAP3 (0.41) LAP3S1PR4S1PR1S1PR3S1PR5
SCHEMBL9742659 0.88 LAP3 (0.41) LAP3S1PR4S1PR1S1PR3S1PR5
SCHEMBL9745371 0.88 LAP3 (0.41) LAP3S1PR4S1PR1S1PR3S1PR5
SCHEMBL9744820 0.87 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19LAP3METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed